Figure 5From: Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in miceSerum AST and ALT levels in abdominally spread tumor model mice after intraperitoneal drug administration. A and B: Serum AST and ALT levels: Serum samples were collected before treatment started (day0), and one(day1) and 14 days(day14) after the last treatment.Back to article page